These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3515659

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
    Mrsić M, Labar B, Bogdanić V, Nemet D, Pavletić Z, Plavsić F, Dobrić I, Kastelan A, Marusić M, Zupancić-Salek S.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
    Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V.
    N Engl J Med; 1986 Mar 20; 314(12):729-35. PubMed ID: 3513012
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
    Truog AW, Wozniak SP.
    Oncol Nurs Forum; 1990 Mar 20; 17(1):39-44. PubMed ID: 2405360
    [Abstract] [Full Text] [Related]

  • 6. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.
    Forman SJ, Blume KG, Krance RA, Miner PJ, Metter GE, Hill LR, O'Donnell MR, Nademanee AP, Snyder DS.
    Transplant Proc; 1987 Feb 20; 19(1 Pt 3):2605-7. PubMed ID: 3079090
    [No Abstract] [Full Text] [Related]

  • 7. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
    Storb R, Deeg HJ, Whitehead J, Farewell V, Appelbaum FR, Beatty P, Bensinger W, Buckner CD, Clift RA, Doney K.
    Transplant Proc; 1987 Feb 20; 19(1 Pt 3):2608-13. PubMed ID: 3547942
    [No Abstract] [Full Text] [Related]

  • 8. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Gluckman E, Devergie A, Lokiec F.
    Transplant Proc; 1988 Jun 20; 20(3 Suppl 3):461-9. PubMed ID: 3291282
    [No Abstract] [Full Text] [Related]

  • 9. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
    Weisdorf D, Filipovich A, McGlave P, Ramsay N, Kersey J, Miller W, Blazar B.
    Bone Marrow Transplant; 1993 Nov 20; 12(5):531-6. PubMed ID: 8298565
    [Abstract] [Full Text] [Related]

  • 10. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.
    Bone Marrow Transplant; 2001 Jul 20; 28(2):187-96. PubMed ID: 11509937
    [Abstract] [Full Text] [Related]

  • 11. Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
    Leelasiri A, Greer JP, Stein RS, Goodman S, Brandt SA, Edwards JR, Wolff SN.
    Bone Marrow Transplant; 1995 Mar 20; 15(3):401-5. PubMed ID: 7599565
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL, Bloom EJ.
    Clin Pharm; 1993 Oct 20; 12(10):736-61. PubMed ID: 8258255
    [Abstract] [Full Text] [Related]

  • 13. Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
    Tollemar J, Ringdén O, Heimdahl A, Lönnqvist B, Sundberg B.
    Transplant Proc; 1988 Jun 20; 20(3 Suppl 3):470-9. PubMed ID: 3291283
    [No Abstract] [Full Text] [Related]

  • 14. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gluckman E, Reiffers J, Vernant JP, Jouet JP, Harrousseau JL, Fiere D, Bacigalupo A, Frassoni F, Gorin NC.
    Bone Marrow Transplant; 1996 Nov 20; 18(5):921-9. PubMed ID: 8932846
    [Abstract] [Full Text] [Related]

  • 15. Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
    Tollemar J, Ringdén O, Sundberg B, Bolme P, Brattström C, Gahrton G, Johansen L, Lönnqvist B.
    Transplant Proc; 1988 Jun 20; 20(3):494-8. PubMed ID: 3381257
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
    Bacigalupo A, Frassoni F, van Lint MT, Raffo MR, Vitale V, Corbetta G, Chierichetti S, Marmont AM.
    Exp Hematol; 1985 May 20; 13(4):244-8. PubMed ID: 3886417
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
    Remberger M, Ringden O, Aschan J, Ljungman P, Lönnqvist B, Markling L.
    Transplant Proc; 1994 Jun 20; 26(3):1829-30. PubMed ID: 8030159
    [No Abstract] [Full Text] [Related]

  • 18. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N, Yano K, Yokomaku S, Morishima Y, Iwamura H, Naito K, Kodera Y, Matsuyama K, Nakaide Y, Yamada H.
    Rinsho Ketsueki; 1988 Mar 20; 29(3):313-9. PubMed ID: 3294471
    [No Abstract] [Full Text] [Related]

  • 19. [Cyclosporine in allogeneic bone marrow transplantation in children].
    Kojima S, Fukuda M, Horibe K, Matsuyama K.
    Rinsho Ketsueki; 1987 Sep 20; 28(9):1576-82. PubMed ID: 3325658
    [No Abstract] [Full Text] [Related]

  • 20. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A.
    Exp Hematol; 1995 Dec 20; 23(14):1503-8. PubMed ID: 8542938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.